14 enrolling by invitation. 14 Phase 2, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Enrolling by invitation 14 |
| Phase 1 | 6 | Enrolling by invitation 6 |
Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM Busulfan, Palifermin, Plerixafor - WHIM, Warts | Phase 1 / Phase 2 | Enrolling by invitation | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2026-10-21 | 2026-10-27 |
| DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury DMSO-based otic solution with betahistine, dexamethasone, and lidocaine, DMSO-based transdermal cream with levocarnitine and N-acetylcysteine - Tinnitus | Phase 2 | Enrolling by invitation | Leading Edge Clinic | 20 | 2026-05-15 | 2026-05-13 |
| Racecadotril for Organ Injury in Sepsis Patients Racecadotril, Water (Placebo) - Sepsis | Phase 1 / Phase 2 | Enrolling by invitation | Zhujiang Hospital | 44 | 2026-05-06 | 2026-05-28 |
| Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease Contezolid, linezolid - Monotherapy, Mycobacterium Abscessus Infection | Phase 2 | Enrolling by invitation | Beijing Chest Hospital | 24 | 2026-01-01 | 2026-01-28 |
| To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated Thrombocytopenia Carica Papaya Leaf Extract Group, standard treatment - Dengue Fever, Papaya Leaf Extract | Phase 2 | Enrolling by invitation | Ziauddin Hospital | 100 | 2025-10-01 | 2025-09-15 |
| Assessing the Safety and Efficacy of a Combination Therapy for STH in PSAC in Bangladesh A single dose of Albendazole 400mg + Ivermectin (200 µg/ kg) combination therapy, A single dose of 400 mg Oral Albendazole monotherapy - Soil Transmitted Helminth (STH) Infections | Phase 2 | Enrolling by invitation | International Centre for Diarrhoeal Disease Research, Bangladesh | 110 | 2025-07-10 | 2025-08-14 |
| Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease Sitafloxacin - Fluoroquinolone, Mycobacterium | Phase 2 | Enrolling by invitation | Beijing Chest Hospital | 12 | 2025-01-28 | 2025-02-05 |
| Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma. BioTTT001 injection - Recurrent High-grade Glioma | Phase 1 / Phase 2 | Enrolling by invitation | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 30 | 2024-11-26 | 2026-03-23 |
| Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services Peer distribution of self testking kits - HIV, Syphilis | Phase 2 | Enrolling by invitation | Makerere University | 200 | 2024-08-25 | 2025-01-24 |
| Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis Contezolid, Linezolid (LZD) - Tuberculosis, Meningitis | Phase 1 / Phase 2 | Enrolling by invitation | Beijing Chest Hospital | 24 | 2024-02-01 | 2025-02-06 |
| Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis Contezolid, Linezolid (LZD) - Tuberculosis, Bone | Phase 1 / Phase 2 | Enrolling by invitation | Beijing Chest Hospital | 24 | 2024-01-31 | 2025-02-06 |
| Anti-viral T-cell Therapy by Gamma Capture Specific T- Lymphocytes - Adenovirus, Cytomegalovirus Infections | Phase 1 / Phase 2 | Enrolling by invitation | Paul Szabolcs | 25 | 2024-01-08 | 2026-06-29 |
| Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 IV normal saline, IV immunoglobulin - Systemic Inflammation, Neuroinflammation | Phase 2 | Enrolling by invitation | National Institute of Neurological Disorders and Stroke (NINDS) | 45 | 2023-07-10 | 2026-11-09 |
| SPI-1005 Treatment in Moderate COVID-19 Patients Ebselen, Placebo - Covid19, Corona Virus Infection | Phase 2 | Enrolling by invitation | Sound Pharmaceuticals, Incorporated | 60 | 2021-10-12 | 2023-10-03 |
Adenoviridae Infections (2) · COVID-19 (2) · Mycobacterium Infections, Nontuberculous (2) · Post-Acute COVID-19 Syndrome (2) · Tuberculosis (2) · Agammaglobulinemia (1) · Coronavirus Infections (1) · Cytomegalovirus Infections (1) · Dengue (1) · Epstein-Barr Virus Infections (1) · Glioma (1) · Immunologic Deficiency Syndromes (1) · Meningitis (1) · Mycobacterium Infections (1)
Virus Diseases (7) · Bacterial Infections (5) · Bacterial Infections and Mycoses (5) · Actinomycetales Infections (4) · Gram-Positive Bacterial Infections (4) · RNA Virus Infections (4) · Coronaviridae Infections (3) · DNA Virus Infections (3) · Lung Diseases (3) · Mycobacterium Infections (3) · Nervous System Diseases (3) · Nidovirales Infections (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3)
Linezolid (3) · contezolid (3) · Acetylcysteine (1) · Albendazole (1) · Betahistine (1) · Busulfan (1) · Carnitine (1) · Combined Modality Therapy (1) · Dexamethasone (1) · Fibroblast Growth Factor 7 (1) · Filgrastim (1) · Immunoglobulins, Intravenous (1) · Ivermectin (1) · Lidocaine (1) · Oxazolidinones (1)
Beijing Chest Hospital (4) · Beijing Bio-Targeting Therapeutics Technology Co., Ltd (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · Leading Edge Clinic (1) · Makerere University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Paul Szabolcs (1) · Sound Pharmaceuticals, Incorporated (1) · Zhujiang Hospital (1) · Ziauddin Hospital (1)
China (6) · United States (5) · Bangladesh (1) · Pakistan (1) · Uganda (1)
Avindra Nath, M.D. (1) · Barbara A Castelnuovo, MD, MPH. PhD (1) · Miriam Treggiari, MD (1) · Paul Szabolcs, MD (1) · Scott D Marsland, MS Nursing (1) · Stephen Okoboi, BSc, MPH, PhD (1) · Suk S De Ravin, M.D. (1) · Syed Nazin Morshed, MBBS (1) · Wenjuan Nie, Director (1) · Zhanguo Liu, M.D.PhD (1)
PMID 12474486, PMID 12592987, PMID 16713738, PMID 17426180, PMID 18414647, PMID 19265242, PMID 19589144, PMID 23675549, PMID 26401658, PMID 28947636, PMID 29329288, PMID 29702653, PMID 30768602, PMID 32397986, PMID 32953118, PMID 33284834, PMID 33292853, PMID 37202027, PMID 37930980, PMID 38163912, PMID 38321011, PMID 8940976